2026-06-11T18:50:43-04:00 2025-08-31 454570537 MARJTAX INCORPORATED 3542 FRUITVALE- AVE PMB 227 OAKLAND CA 94602 990 2024-09-01 232819070 INTERNATIONAL NEUROMODULATION SOCIETY INTE 4156833237 2000 VAN NESS AVENUE SUITE 414 SAN FRANCISCO CA 94109 TIA SOFATZIS EXECUTIVE DIRECTOR 4156833237 2026-06-11 true false MARJORIE WILLIAMS-JONES P00564614 5104826204 2026-06-11 X 2024 2025-03-06 01:10:19Z PHILLIPE RIGOARD 2000 VAN NESS AVE -SUITE 414 SAN FRANCISCO CA 94109 653817 false X WWW.NEUROMODULATION.COM X 1995 PA THE INS HOSTS MONTHLY WEBINARS FEATURING RENOWNED EXPERTS FOR MEDICAL PROFESSIONALS TO LEARN THE LATEST NEUROMODULATION RESEARCH, THERAPIES & BEST PRACTICES TO IMPROVE PATIENT SELECTION, ACCESS & CARE. 40 40 3 0 876591 255039 1061754 316313 72326 35143 48553 47322 2059224 653817 10212 30758 0 593541 576696 0 0 1888206 194002 2491959 801456 -432735 -147639 1822067 1729730 219286 252874 1602781 1476856 X TO CREATE A FORUM FOR CLINICIANS, BASIC SCIENTISTS & BIOENGINEERS INVOLVED WITH NEUROMODULATION THRU A COMBINATION OF SCIENTIFIC MEETINGS, WEBINARS, JOURNAL, PODCAST AND INTERACTIVE WEBSITE (COMPLETE STATEMENT ON SCHED O) false false 365538 THE SOCIETY PRODUCES A PEER-REVIEWED, SCIENTIFIC JOURNAL, NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, WHICH IS INDEXED BY THE NATIONAL LIBRARY OF MEDICINE IN MEDLINE / PUBMED AND IS PUBLISHED EIGHT TIMES A YEAR. NEUROMODULATION IS THE PREEMINENT JOURNAL IN THE AREA OF NEUROMODULATION, PROVIDING OUR READERSHIP WITH THE STATE OF THE ART CLINICAL, TRANSLATIONAL AND BASIC SCIENCE RESEARCH IN OUR FIELD AND REPRESENTING THE NEEDS OF THE BROAD NEUROMODULATION COMMUNITY. (CONTINUES ON SCHEDULE O) 103047 OTHER INS PROGRAMS TO PROMOTE INTERDISCIPLINARY STUDIES AND FURTHER EDUCATIONAL EFFORTS IN THE FIELD OF NEUROMODULATION THROUGH SCIENTIFIC MEETINGS, PODCAST AND QUARTERLY NEWSLETTERS. 92389 INTERNATIONAL NEUROMODULATION SOCIETY ORGANIZES ITS WEBINARS, JOURNAL CLUBS, AND BIENNIAL WORLD CONGRESSES WITH THE AIM OF BRINGING TOGETHER AN INTERNATIONAL COMMUNITY OF PROFESSIONALS FROM MULTIPLE DISCIPLINES, WHO WOULD NOT OTHERWISE MEET, TO LEARN ABOUT THE BROAD SPECTRUM OF NEUROMODULATION SCIENCE AND THERAPIES. THE INS'S MISSION IS TO PROMOTE AND DISSEMINATE THE SCIENCE, EDUCATION, PRACTICE AND ACCESSIBILITY OF ALL ASPECTS OF NEUROMODULATION. THIS MULTIDISCIPLINARY SOCIETY BELIEVES THAT ALL SCIENTISTS, CLINICIANS, BIOENGINEERS, PROFESSIONS ALLIED TO MEDICINE, AND INDUSTRY PARTNERS WHO HAVE A SPECIALIST INTEREST IN NEUROMODULATION, CAN AND SHOULD WORK WITH THIS SOCIETY TO SHARE SCIENCE AND ENCOURAGE BEST PRACTICE FOR THE GOOD OF HUMANITY. (CONTINUES ON SCHEDULE O). 160379 30758 THE INTERNATIONAL NEUROMODULATION SOCIETY HOSTS THE NEUROMODULATION PODCAST TO EXPLORE THE FOREFRONT OF EMERGING NEUROMODULATION TECHNIQUES, INSIGHTS, AND ETHICAL AND CLINICAL APPLICATIONS. FROM CLINICIANS AND PATIENTS TO RESEARCHERS AND ENGINEERS, THE NEUROMODULATION PODCAST EXPANDS THE REACH AND IMPACT OF OUR SOCIETY BY SHARING THE VOICE OF NEUROMODULATION GLOBALLY. INNOVATIVE RESEARCH GRANT PROGRAM THE INS INITIATED ITS INNOVATIVE RESEARCH GRANT PROGRAM IN FYE 2022 AND CONTINUED IT IN FYE 2024. THE AIMS OF THIS PROGRAM ARE TO: PROVIDE AN EARLY RESEARCH EXPERIENCE TO JUNIOR NEUROMODULATORS, WHETHER THEY BE HEALTH CARE PROVIDERS, CLINICAL RESEARCHERS, SCIENTISTS OR ENGINEERS; PROVIDE THE OPPORTUNITY TO CREATE INITIAL FINDINGS WHICH LEAD TO EXTERNAL FUNDING AND DEVELOPMENT OF A LONG-TERM RESEARCH PROGRAM; THROUGH INTERACTION WITH A RESEARCH MENTOR, TEACH INS MEMBERS THE CRITICAL SKILLS REQUIRED TO EVALUATE NEUROMODULATION SCIENCE AND TO BEGIN A CAREER THAT INVOLVES HIGH QUALITY NEUROMODULATION RESEARCH; AND PROVIDE SCIENTISTS, CLINICIANS AND PATIENTS WITH IMPORTANT NEW FINDINGS THAT LEAD TO IMPROVEMENTS IN SAFETY AND EFFICACY IN OUR FIELD. 160379 30758 721353 true true false false false false false false false false true false false false true false false false false false true true false false false false false false false true false false false false false false false false false false false false false false false false false true 5 0 true 3 true false false false false false false false false false false false false false false X 40 40 false false false false false false false true true false false true true true true true true true false false CA X TIA SOFATZIS 4156833237 2000 VAN NESS AVE -SUITE 414 SAN FRANCISCO CA 94109 KONSTANTIN SLAVIN PRESIDENT 10.00 X X 0 0 0 MARC RUSSO IMMED PAST-P 10.00 X X 0 0 0 ROBERT M LEVY EDITOR-IN-CH 10.00 X 221900 0 0 JAN VESPER PRESIDENT-EL 10.00 X X 0 0 0 LAWRENCE POREE SECRETARY 10.00 X X 0 0 0 PHILLIPE RIGOARD TREASURER 10.00 X 0 0 0 TIA SOFATZIS EXECUTIVE DI 40.00 X 151927 0 0 ENRIQUE BRICHETTI CHAPTER PRES 1.00 X 0 0 0 MICHELLE O'BRIEN CHAPTER PRES 1.00 X 0 0 0 LISA GOUDMAN CHAPTER PRES 1.00 X 0 0 0 HOUGELLE SIMPLICIO CHAPTER PRES 1.00 X 0 0 0 ANUJ BHATIA CHAPTER PRES 1.00 X 0 0 0 JIAN-GUO ZHANG CHAPTER PRES 1.00 X 0 0 0 DIRK RASCHE CHAPTER PRES 1.00 X 0 0 0 ANDREA LANDI CHAPTER PRES 1.00 X 0 0 0 HIDEHIRO HIRABAYASHI CHAPTER PRES 1.00 X 0 0 0 TAE-KYU LEE CHAPTER PRES 1.00 X 0 0 0 AHMED RASLAN CHAPTER PRES 1.00 X 0 0 0 EFSTATHIOS BOVIATIS CHAPTER PRES 1.00 X 0 0 0 CARLOS TORNERO CHAPTER PRES 1.00 X 0 0 0 MATTHIEU CACHEMAILLE CHAPTER PRES 1.00 X 0 0 0 JAMES FITZGERALD CHAPTER PRES 1.00 X 0 0 0 WITEK LIBIONKA CHAPTER PRES 1.00 X 0 0 0 KLIMENT GATZINSKY CHAPTER PRES 1.00 X 0 0 0 GUL TALU CHAPTER PRES 1.00 X 0 0 0 DENYS FONTAINE CHAPTER PRES 1.00 X 0 0 0 PARESH DOSHI CHAPTER PRES 1.00 X 0 0 0 ALIF RAHMAN CHAPTER PRES 1.00 X 0 0 0 RUTH GUR CHAPTER PRES 1.00 X 0 0 0 CHINGIZ SHASHKIN CHAPTER PRES 1.00 X 0 0 0 HANS CARMONA CHAPTER PRES 1.00 X 0 0 0 MARIANO VEIGA CHAPTER PRES 1.00 X 0 0 0 EMIL ISAGULYAN CHAPTER PRES 1.00 X 0 0 0 KIRAN PATEL DIRECTOR AT 1.00 X 0 0 0 CHRIS GILLIGAN DIRECTOR AT 1.00 X 0 0 0 STANA BOJANIC DIRECTOR AT 1.00 X 0 0 0 ASHISH GULVE REGIONAL DIR 1.00 X 0 0 0 GUOMING LUAN REGIONAL DIR 1.00 X 0 0 0 ARTHUR CUKIERT REGIONAL DIR 1.00 X 0 0 0 PHILLIPE RIGOARD DIRECTOR AT 1.00 X 0 0 0 DANIEL BENZECRY REGIONAL DIR 1.00 X 0 0 0 STANA BOJANIC REGIONAL DIR 1.00 X 0 0 0 373827 2 false true false 255039 255039 MEMBER DUES + SUBSCRIPTIONS 541700 228467 228467 SUBSCRIPTION FEE INCOME 541700 130763 130763 EDITORIAL OFFICE STIPEND 541700 126097 126097 CHAPTER DUES 541700 17832 17832 STRATEGIC DEVELOPMENT 541700 5000 5000 -191846 -191846 316313 27908 27908 47322 47322 7235 7235 7235 7235 653817 323548 75230 30758 30758 373827 335845 37982 166010 166010 12749 12749 24110 21204 2906 3710 3710 22724 22724 6113 6113 34557 34557 1957 1494 463 21467 20300 1167 12773 9217 3556 84754 84754 18 18 5929 4447 1482 801456 721353 80103 0 189082 182284 8559 10500 185000 80161 68499 1000 1000 288 288 1502279 1254376 39045 30012 1822067 1729730 84302 115406 134984 137468 219286 252874 X 1522044 1396119 80737 80737 1602781 1476856 1822067 1729730 -147639 21714 X false false false X 354950 916391 334500 876591 255039 2737471 273182 1204428 293025 1110307 316313 3197255 628132 2120819 627525 1986898 571352 5934726 260000 587141 190500 634400 185000 1857041 173955 120577 114693 156988 171953 738166 433955 707718 305193 791388 356953 2595207 3339519 814 695 23156 32009 75230 131904 814 695 23156 32009 75230 131904 628946 2121514 650681 2018907 646582 6066630 0.55050 0.57280 0.02000 0.01000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 288 288 ACCRUED PAID TIME OFF 87475 LEASE ROU - LONG TERM LIABILITY 16541 CHASE CARD SERVICES 15263 LEASE ROU - CURENT LIABILITY 14112 ACCRUED PAYROLL 7353 INCOME IN TRANSIT -3276 137468 true EAST ASIA AND THE PACIFIC RESEARCH GRANT AGENCY MISSION 4879 EUROPE RESEARCH GRANT AGENCY MISSION 25879 30758 30758 EUROPE RESEARCH GRANT 25879 WIRES false false false false false false SCHEDULE F, PAGE 1, PART I, LINE 3 EAST ASIA AND THE PACIFIC 4,879 0 EUROPE 25,879 0 X X X false false false false false false false false false ROBERT M LEVY EDITOR-IN-CHIEF 221900 221900 TIA SOFATZIS EXECUTIVE DIRECTOR 151927 151927 FORM 990, PART III MOST SIGNIFICANT ACTIVITIES THE INS HOSTS MONTHLY WEBINARS FEATURING RENOWNED EXPERTS FOR MEDICAL PROFESSIONALS TO LEARN THE LATEST NEUROMODULATION RESEARCH, THERAPIES & BEST PRACTICES TO IMPROVE PATIENT SELECTION, ACCESS & CARE. IN LINE WITH ITS EDUCATIONAL MISSION, THE INS, WITH ITS YOUNG NEUROMODULATOR AND INTERNATIONAL WOMEN IN NEUROMODULATION COMMITTEES, HOSTS THE VIRTUAL JOURNAL CLUB TO OFFER AN OBJECTIVE, NON-COMMERCIAL PLATFORM FOR DISCUSSING TIMELY STUDIES OF NEUROMODULATION TECHNIQUES AND CLINICAL PRACTICE. MANY ARTICLES COME FROM NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, THE OFFICIAL JOURNAL OF THE INS. CME CREDIT IS AVAILABLE TO MEMBERS WHO PARTICIPATE IN THE LIVE EVENT. EACH CLUB SESSION IS RECORDED AND MADE AVAILABLE ON THE INS MEMBERS' WEBSITE FOR LATER VIEWING. COMPLETE MISSION STATEMENT OF INTERNATIONAL NEUROMODULATION SOCIETY: THE MISSION OF THE INS IS TO PROMOTE AND DISSEMINATE THE SCIENCE, EDUCATION, PRACTICE AND ACCESSIBILITY OF ALL ASPECTS OF NEUROMODULATION. THIS MULTIDISCIPLINARY SOCIETY BELIEVES THAT ALL SCIENTISTS, DOCTORS, BIOENGINEERS, PROFESSIONS ALLIED TO MEDICINE AND INDUSTRY PARTNERS WHO HAVE A SPECIALIST INTEREST IN NEUROMODULATION CAN WORK WITH THIS SOCIETY TO SHARE SCIENCE AND ENCOURAGE BEST PRACTICE FOR THE GOOD OF HUMANITY. THE VISION OF THE INS IS TO HARNESS ALL SCIENTIFIC, CLINICAL AND ENGINEERING ENDEAVOR THROUGHOUT THE WORLD AND TO BRAND NEUROMODULATION TO ENCOMPASS ALL NEUROLOGICAL TECHNOLOGIES THAT THROUGH ELECTRICAL OR CHEMICAL MEANS IMPROVE THE FUNCTION OF THE IMPAIRED INDIVIDUAL. THE GOALS OF THE INS ARE: TO CREATE A FORUM FOR CLINICIANS, BASIC SCIENTISTS AND BIOENGINEERS INVOLVED WITH NEUROMODULATION THROUGH A COMBINATION OF SCIENTIFIC MEETINGS, JOURNAL AND INTERACTIVE WEBSITE; TO CREATE A FAMILY OF AFFILIATED NEUROMODULATION NATIONAL CHAPTERS TO ENCOURAGE GROWTH AND INFLUENCE AT NATIONAL LEVEL; TO ENCOURAGE RESEARCH AND DEVELOPMENT INTO THE CONDITIONS TREATED AND THE DEVICES AND TECHNIQUES USED; TO ENCOURAGE OPEN DIALOGUE WITH INDUSTRY PARTNERS AND HEALTH CARE AUTHORITIES TO IMPROVE UNDERSTANDING OF THESE THERAPIES, THE NEEDS OF PATIENTS, SERVICE REQUIREMENTS AND FAIR REMUNERATION; TO EXPAND THE WORLDWIDE ACCESS TO NEUROMODULATION BY RAISING AWARENESS OF THE BOTH ITS CLINICAL EFFICACY AND COST EFFECTIVENESS. PROGRAM SERVICE ACCOMPLISHMENT STATEMENT1, CONTINUED: FOR CLINICIANS, ENGINEERS, SCIENTISTS AND MEMBERS OF THE BIOTECHNOLOGY INDUSTRY ALIKE, NEUROMODULATION PROVIDES TIMELY AND RIGOROUSLY PEER REVIEWED ARTICLES ON THE TECHNOLOGY, SCIENCE AND CLINICAL APPLICATION OF DEVICES THAT INTERFACE WITH THE NERVOUS SYSTEM TO TREAT DISEASE AND IMPROVE FUNCTION. NEUROMODULATION COVERS AN EVER EXPANDING FIELD INCLUDING PAIN, HEADACHE, MOVEMENT DISORDERS, SPASTICITY, PARALYSIS, PSYCHIATRIC DISORDERS, COGNITIVE DISORDERS, EPILEPSY, SENSORY DEPRIVATION, GASTRIC DYSFUNCTION, OBESITY, INCONTINENCE AND SYSTEMIC DISEASE. THE JOURNAL REPRESENTS THE PRACTICE OF A GROWING, DIVERSE MULTIDISCIPLINARY FIELD RESPONSIBLE FOR THE DEVELOPMENT AND APPLICATION OF DEVICES AND TECHNIQUES TO BENEFIT PATIENTS BY NORMALIZING FUNCTION AND REDUCING SUFFERING. IN DEPTH REVIEWS, ORIGINAL ARTICLES, NATIONAL AND INTERNATIONAL MEETING ABSTRACTS, SPECIAL FOCUS EDITIONS AND WEB BASED EDUCATIONAL OFFERINGS HELP THE READER TO EXPAND THEIR KNOWLEDGE AND UNDERSTANDING OF THE INTERFACE BETWEEN ELECTRICAL STIMULATION, CHEMICAL NEUROMODULATION, THE NERVOUS SYSTEM AND THE PATIENT. OUR UPDATES ON PAST AND FUTURE NEWS OF EVENTS AND ACTIVITIES OF THE INS AND ITS MEMBERSHIP KEEP THE READER ABREAST OF ISSUES RELATED TO PROFESSIONAL EDUCATION AND DEVELOPMENT. PROGRAM SERVICE ACCOMPLISHMENT STATEMENT3, CONTINUED: THEREFORE, THIS CONFERENCE WILL APPEAL TO AND EDUCATE THE DIVERSE POPULATION OF ANTICIPATED ATTENDEES (NEUROSURGEONS, NEUROLOGISTS, ANESTHESIOLOGISTS, PHYSIATRISTS, CARDIOLOGISTS, UROLOGISTS, BASIC SCIENTISTS, ALLIED HEALTHCARE PROFESSIONALS, BIOMEDICAL ENGINEERS, AND INDUSTRY REPRESENTATIVES) FROM AROUND THE GLOBE AND PROVIDE A UNIQUE FORUM FOR DISCOURSE. AMONGST SOME SPECIALISTS OUTSIDE OF THE NEUROMODULATION COMMUNITY, THERE IS A GENERAL LACK OF AWARENESS AND/OR SKEPTICISM OF THE TECHNOLOGY AND THERAPIES AVAILABLE TO THEIR PATIENTS AND THE INS STRIVES TO EDUCATE THE UNINITIATED AND DISPEL ANY MISINFORMATION ABOUT THE EXISTENCE AND EFFECTIVENESS OF NEUROMODULATION TO TREAT MOVEMENT DISORDERS, PSYCHIATRIC DISORDERS, CHRONIC PAIN, ANGINA, PERIPHERAL VASCULAR DISEASE, BLADDER DYSFUNCTION AND GASTROINTESTINAL / COLORECTAL DYSFUNCTION, ETC. IT IS THEREFORE INCUMBENT UPON OUR SOCIETY TO BRIDGE THE GAPS BETWEEN SPECIALTIES AND CONTINENTS, TO EDUCATE AND ENABLE EXCHANGE OF THIS SCIENTIFIC INFORMATION AND, ULTIMATELY, TO PROVIDE THE TOOLS NEEDED TO IMPROVE PATIENT CARE. FORM 990, PAGE 2, PART III, LINE 4D THE INTERNATIONAL NEUROMODULATION SOCIETY HOSTS THE NEUROMODULATION PODCAST TO EXPLORE THE FOREFRONT OF EMERGING NEUROMODULATION TECHNIQUES, INSIGHTS, AND ETHICAL AND CLINICAL APPLICATIONS. FROM CLINICIANS AND PATIENTS TO RESEARCHERS AND ENGINEERS, THE NEUROMODULATION PODCAST EXPANDS THE REACH AND IMPACT OF OUR SOCIETY BY SHARING THE VOICE OF NEUROMODULATION GLOBALLY. INNOVATIVE RESEARCH GRANT PROGRAM THE INS INITIATED ITS INNOVATIVE RESEARCH GRANT PROGRAM IN FYE 2022 AND CONTINUED IT IN FYE 2024. THE AIMS OF THIS PROGRAM ARE TO: PROVIDE AN EARLY RESEARCH EXPERIENCE TO JUNIOR NEUROMODULATORS, WHETHER THEY BE HEALTH CARE PROVIDERS, CLINICAL RESEARCHERS, SCIENTISTS OR ENGINEERS; PROVIDE THE OPPORTUNITY TO CREATE INITIAL FINDINGS WHICH LEAD TO EXTERNAL FUNDING AND DEVELOPMENT OF A LONG-TERM RESEARCH PROGRAM; THROUGH INTERACTION WITH A RESEARCH MENTOR, TEACH INS MEMBERS THE CRITICAL SKILLS REQUIRED TO EVALUATE NEUROMODULATION SCIENCE AND TO BEGIN A CAREER THAT INVOLVES HIGH QUALITY NEUROMODULATION RESEARCH; AND PROVIDE SCIENTISTS, CLINICIANS AND PATIENTS WITH IMPORTANT NEW FINDINGS THAT LEAD TO IMPROVEMENTS IN SAFETY AND EFFICACY IN OUR FIELD. FORM 990, PAGE 6, PART VI, LINE 11B THE TREASURER, BOOKKEEPER AND EXECUTIVE DIRECTOR REVIEW THE FORM 990 INDEPENDENTLY AND PROVIDE THEIR COMMENTS, IF ANY, TO THE ACCOUNTANT PREPARING THE FORM. FORM 990, PAGE 6, PART VI, LINE 12C INS HAS A CONFLICTS POLICY IN PLACE, BUT NO CONFLICTS HAVE ARISEN AS OF YET. FORM 990, PAGE 6, PART VI, LINE 15A THE ANNUAL PROCESS FOR DETERMINING COMPENSATION IS AS FOLLOWS: THE INS EXECUTIVE BOARD SHALL ANNUALLY EVALUATE THE EXECUTIVE DIRECTOR, PUBLIC EDUCATION MANAGER, AND EDITORIAL ASSISTANT ON HIS/HER PERFORMANCE, AND ASK FOR HIS/HER INPUT ON MATTERS OF PERFORMANCE AND COMPENSATION. THE EXECUTIVE BOARD WILL OBTAIN RESEARCH AND INFORMATION TO INFORM THEIR DECISION ON THE COMPENSATION (SALARY AND BENEFITS) BASED ON A REVIEW OF COMPARABILITY DATA FORM 990, PAGE 6, PART VI, LINE 19 THE GOVERNING DOCUMENTS (BYLAWS) AND COI POLICY ARE POSTED ON THE WEBSITE. THE FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.